PLEASE SCAN QR CODE

TO VERIFY THE REPORT ONLINE

25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114633

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:11 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF HEMATOPATHOLOGY
Blood Grouping ABO And Rh Typing
Parameter Results

Blood Grouping (ABO) O

Rh Typing (D) Positive
Method:Hemagglutination Tube Method by Forward &
Reverse Grouping

Method: Hemagglutination Tube Method by Forward & Reverse Grouping

Reference: Tulip kit literature

Interpretation: The ABO grouping and Rh typing test determines blood type grouping (A,B, AB, O ) and the Rh factor
(positive or negative). A person's blood type is based on the presence or absence of certain antigens on the surface
of their red blood cells and certain antibodies in the plasma. ABO antigens are poorly expresses at birth, increase
gradually in strength and become fully expressed around 1 year of age.
In case of Rh(D) - Du(weak positive) or Weak D positive, the individual must be considered as Rh positive as donor
and Rh negative as recipient.

Note: Records of previous blood grouping/Rh typing not available. Please verify before transfusion.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Shaikh Ayeesha
Consultant Hematopathologist
[Link] - TSMC/FMR/00158

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:53 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Blood Urea Nitrogen (BUN)
Investigation Observed Value Biological Reference Interval

Blood Urea Nitrogen. 6 6-20 mg/dL

Method:Calculated

Interpretation: Urea is a waste product formed in the liver when protein is metabolized. Urea is released by the liver
into the blood and is carried to the kidneys, where it is filtered out of the blood and released into the urine. Since this
is a continuous process, there is usually a small but stable amount of urea nitrogen in the blood. However, when the
kidneys cannot filter wastes out of the blood due to disease or damage, then the level of urea in the blood will rise.
The blood urea nitrogen (BUN) evaluates kidney function in a wide range of circumstances, to diagnose kidney
disease, and to monitor people with acute or chronic kidney dysfunction or failure. It also may be used to evaluate a
person's general health status as well.

Reference: Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:53 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Calcium, Serum
Investigation Observed Value Biological Reference Interval

Calcium 8.7 8.6-10.0 mg/dL

Method:BAPTA

Interpretation: Calcium is essential for bones, heart, nerves, kidneys, and teeth. Serum calcium levels are vital to
detect hypocalcemia, hypercalcemia and associated disorders. Parathormone (PTH) and vitamin D are responsible
for maintaining calcium concentrations in the blood within a narrow range of values. Serum calcium levels are
diagnostic in cases of Kidney stones, Bone diseases and Neurologic disorders.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114633

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 15:51 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF HEMATOPATHOLOGY
Complete Blood Picture (CBP)
Investigation Observed Value Biological Reference Interval

Hemoglobin 14.3 13.0-17.0 g/dL

Method:Spectrophotometry

PCV/HCT 43.0 40.0-50.0 vol%

Method:Calculated

Total RBC Count 5.16 4.50-5.50 mill /[Link]

Method:Electrical Impedance

MCV 83.3 83.0-101.0 fL

Method:Calculated

MCH 27.8 27.0-32.0 pg

Method:Calculated

MCHC 33.3 31.5-34.5 g/dL

Method:Calculated

RDW (CV) 14.9 11.6-14.0 %

Method:Calculated

MPV 8.1 7.0-10.0 fL

Method:Calculated

Total WBC Count 6790 4000-10000 cells/cumm

Method:Electrical Impedance

Platelet Count 2.78 1.50-4.10 lakhs/cumm

Method:Electrical Impedance

Differential Count
Neutrophils 63.3 40.0-80.0 %
Lymphocytes 26.0 20.0-40.0 %
Eosinophils 3.2 1.0-6.0 %
Monocytes 7.2 2.0-10.0 %
Basophils 0.3 0.0-2.0 %
Method:Flow Cytometer - Microscopy

Absolute Neutrophil Count 4298 2000-7000 cells/cumm

Absolute Lymphocyte Count 1765 1000-3000 cells/cumm
Absolute Eosinophil Count 217 20-500 cells/cumm
Absolute Monocyte Count 489 200-1000 cells/cumm
Absolute Basophil Count 20 20-100 cells/cumm
Method:Calculated

Page 1 of 2
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114633

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 15:51 PM
TEST REPORT Reference : Granules Life Sciences Pri

Neutrophil - Lymphocyte Ratio(NLR) 2.44 0.78-3.53

Method:Calculated

Peripheral Blood Smear Examination

RBC Normocytic normochromic
WBC Normal in Morphology & Distribution
Platelets Adequate
Method:Microscopy

Method: Automated Hematology Analyzer, Microscopy

Reference: Dacie and Lewis Practical Hematology,12th Edition

Interpretation: A Complete Blood Picture (CBP) is a screening test which can aid in the diagnosis of a variety of
conditions and diseases such as anemia, leukemia, bleeding disorders and infections. This test is also useful in
monitoring a person's reaction to treatment when a condition which affects blood cells has been diagnosed. All the
abnormal results are to be correlated clinically.

Note: These results are generated by a fully automated hematology analyzer and the differential count is computed
from a total of several thousands of cells. Therefore the differential count appears in decimalised numbers and may
not add upto exactly 100. It may fall between 99 and 101.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Shaikh Ayeesha
Consultant Hematopathologist
[Link] - TSMC/FMR/00158

Page 2 of 2
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114635

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 16:54 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL PATHOLOGY

Complete Urine Examination (CUE)
Investigation Result Biological Reference Intervals
Physical Examination
Colour Light yellow Straw to Yellow
Method:Physical

Appearance Clear Clear

Method:Physical

Chemical Examination
Reaction and pH Acidic (6.5) 4.6-8.0
Method:Indicator

Specific gravity 1.006 1.000-1.035

Method:Refractometry

Protein Negative Negative

Method:Protein Error of pH indicators

Glucose Negative Negative

Method:Glucose oxidase/Peroxidase

Blood Negative Negative

Method:Peroxidase

Ketones Negative Negative

Method:Sodium Nitroprusside Method

Bilirubin Negative Negative

Method:Diazonium salt

Leucocytes Negative Negative

Method:Esterase reaction

Nitrites Negative Negative

Method:Modified Griess reaction

Urobilinogen Negative Up to 1.0 mg/dl

(Negative)
Method:Diazonium salt

Microscopic Examination
Pus cells (leukocytes) 1-2 2 - 3 /hpf
Method:Flow Digital Imaging/Microscopy

Epithelial cells 1-2 2 - 5 /hpf

Method:Flow Digital Imaging/Microscopy

RBC (erythrocytes) Absent Absent

Method:Flow Digital Imaging/Microscopy

Casts Absent Occasional hyaline casts may be seen

Method:Flow Digital Imaging/Microscopy

Page 1 of 2
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114635

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 16:54 PM
TEST REPORT Reference : Granules Life Sciences Pri

Crystals Absent Phosphate, oxalate, or urate crystals may

Method:Flow Digital Imaging/Microscopy
be seen

Others Nil Nil

Method:Flow Digital Imaging/Microscopy

Method: Semi Quantitative test ,For CUE

Reference: Godkar Clinical Diagnosis and Management by Laboratory Methods, First South Asia edition. Product kit
literature.

Interpretation:

The complete urinalysis provides a number of measurements which look for abnormalities in the urine. Abnormal
results from this test can be indicative of a number of conditions including kidney disease, urinary tract infecation or
elevated levels of substances which the body is trying to remove through the urine . A urinalysis test can help
identify potential health problems even when a person is asymptomatic. All the abnormal results are to be
correlated clinically.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Shaikh Ayeesha
Consultant Hematopathologist
[Link] - TSMC/FMR/00158

Page 2 of 2
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:53 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Creatinine, Serum
Investigation Observed Value Biological Reference Interval

Creatinine. 0.59 0.70-1.20 mg/dL

Method:Alkaline Picrate

Note Kindly correlate clinically

Interpretation:

Creatinine is a nitrogenous waste product produced by muscles from creatine. Creatinine is majorly filtered from the
blood by the kidneys and released into the urine, so serum creatinine levels are usually a good indicator of kidney
function. Serum creatinine is more specific and more sensitive indicator of renal function as compared to BUN
because it is produced from muscle at a constant rate and its level in blood is not affected by protein catabolism or
other exogenous products. It is also not reabsorbed and very little is secreted by tubules making it a reliable marker.
Serum creatinine levels are increased in pre renal, renal and post renal azotemia, active acromegaly and gigantism.
Decreased serum creatinine levels are seen in pregnancy and increasing age.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114633

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 15:51 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF HEMATOPATHOLOGY
Erythrocyte Sedimentation Rate (ESR)
Investigation Observed Value Biological Reference Intervals

ESR 1st Hour 5 <=10 mm/hour

Method:Westergren/Vesmatic

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Shaikh Ayeesha
Consultant Hematopathologist
[Link] - TSMC/FMR/00158

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114633

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 18:16 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Glycosylated Hemoglobin (HbA1C)
Investigation Observed Value Biological Reference Interval

Glycosylated Hemoglobin (HbA1c) 4.8 Non-diabetic: <= 5.6 %

Method:High-Performance Liquid Chromatography Pre-diabetic: 5.7 - 6.4 %
Diabetic: >= 6.5 %
Estimated Average Glucose (eAG) 91 mg/dL
Method:Calculated

Interpretation:

It is an index of long-term blood glucose concentrations and a measure of the risk for developing microvascular
complications in patients with diabetes. Absolute risks of retinopathy and nephropathy are directly proportional to the
mean HbA1c concentration. In persons without diabetes, HbA1c is directly related to risk of cardiovascular disease.

1) Low glycated haemoglobin (below 4%) in a non-diabetic individual are often associated with systemic
inflammatory diseases, chronic anaemia (especially severe iron deficiency & haemolytic), chronic renal failure and
liver diseases. Clinical correlation suggested.

2) Interference of Hemoglobinopathies in HbA1c estimatiion:

A. For HbF > 25%, an alternate platform (Fructosamine) is recommended for testing of HbA1c.
B. Homozygous hemoglobinopathy is detected, fructosamine is recommended for monitoring diabetic status
C. Heterozygous state detected (D10 is corrected for HbS and HbC trait).
3) In known diabetic patients, HbA1c can be considered as a tool for monitoring the glycemic control.
Excellent Control - 6 to 7 %,
Fair to Good Control - 7 to 8 %,
Unsatisfactory Control - 8 to 10 %
and Poor Control - More than 10 %.
Reference: American Diabetes Association. Standards of Medical Care in Diabetes-2022.
* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:26 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF IMMUNOLOGY
Hepatitis B Virus Surface Antigen (HbsAg)
Investigation Observed value Biological Reference Interval

Hepatitis B Surface Antigen <0.02 (Negative) Negative: <0.05 IU/ml

Method:CLIA
Positive: >=0.05 IU/ml

Interpretation:

This test is used to screen for infection with the Hepatitis B (Hep B) virus. The Surface Antigen test looks for a
protein which is present on the surface of the virus. This protein will be present in the blood with an acute or chronic
Hep B infection.

Limitations:

If the HbsAg results are inconsistant with clinical evidence,additional testing is needed to confirm the result.

A Negative test result does not exclude possibility of exposure to or infection with Hepatitis B Virus. Levels of HbsAG
may be undetectable both in early infection and in late after infection

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

[Link] Muneer Ahmed

Consultant Microbiologist
[Link] - APMC/FMR/77996

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 14-Aug-2025 / 09:08 AM
[Link] : 25ASRP0001647 Reported on : 14-Aug-2025 / 13:49 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Lipid Profile
Investigation Observed Value Biological Reference Interval

Total Cholesterol 129 Desirable: <200 mg/dL

Method:Cholesterol Oxidase Borderline: 200-239 mg/dL
High: >/=240 mg/dL
HDL Cholesterol 58 Low: <40 mg/dL
Method:Direct Measurement High: >/=60 mg/dL

VLDL Cholesterol 14.00 6.0-38.0 mg/dL

Method:Calculated

LDL Cholesterol 57 Optimum: <100 mg/dL

Near/above optimum: 100-129 mg/dL
Method:Calculated
Borderline: 130-159 mg/dL
High: 160-189 mg/dL
Very high: >/=190 mg/dL
Triglycerides 70 Normal:<150 mg/dL
Borderline: 150-199 mg/dL
Method:Glycerol LPL/GK
High: 200-499 mg/dL
Very high: >/=500 mg/dL
Chol/HDL Ratio 2.22 Low Risk: 3.3-4.4
Method:Calculated Average Risk: 4.5-7.1
Moderate Risk: 7.2-11.0
LDL Cholesterol/HDL Ratio 0.98 Desirable: 0.5-3.0
Method:Calculated Borderline Risk: 3.0-6.0
High Risk: >6.0
Non HDL Cholesterol 71 <130 mg/dL
Method:Calculated

Interpretation: Lipids are fats and fat-like substances which are important constituents of cells and are rich sources of energy. A
lipid profile typically includes total cholesterol, high density lipoproteins (HDL), low density lipoprotein (LDL), chylomicrons,
triglycerides, very low density lipoproteins (VLDL), Cholesterol/HDL ratio .The lipid profile is used to assess the risk of developing
a heart disease and to monitor its treatment. The results of the lipid profile are evaluated along with other known risk factors
associated with heart disease to plan and monitor treatment. Treatment options require clinical correlation.

Reference: Third Report of the National Cholesterol Education program (NCEP) Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 2001.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:53 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Liver Function Test (LFT)
Investigation Observed Value Biological Reference Interval

Total Bilirubin. 0.56 <1.2 mg/dL

Method:Diazo Method

Direct Bilirubin. 0.18 <0.30 mg/dL

Method:Diazo Method

Indirect Bilirubin. 0.38 <0.9 mg/dL

Method:Calculated

Alanine Aminotransferase ,(ALT/SGPT) 12 <45 U/L

Method:UV wtihout P5P

Aspartate Aminotransferase,(AST/SGOT) 20 <35 U/L

Method:UV wtihout P5P

ALP (Alkaline Phosphatase). 43 40-129 U/L

Method:PNPP-AMP Buffer

Gamma GT. 8 10-71 U/L

Method:GCNA

Total Protein. 7.3 6.6-8.7 g/dL

Method:Biuret

Albumin. 4.4 3.5-5.2 g/dL

Method:Bromocresol Green (BCG)

Globulin. 2.90 1.8-3.8 g/dL

Method:Calculated

A/GRatio. 1.52 0.8-2.0

Method:Calculated

AST/ALT Ratio 1.67 <1.00

Method:Calculated

Interpretation: Liver functions tests help to identify liver disease, its severity, and its type. Generally these tests are
performed in combination, are abnormal in liver disease, and the pattern of abnormality is indicative of the nature of
liver disease. An isolated abnormality of a single liver function test usually means a non-hepatic cause. If several
liver function tests are simultaneously abnormal, then hepatic etiology is likely.
* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:53 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Urea, Serum
Investigation Observed Value Biological Reference Interval

Urea. 12.8 12.8-42.8 mg/dL

Method:Urease

Interpretation: Urea is the major nitrogen-containing metabolic product of protein and amino acid catabolism. It is
increased in pre-renal uraemic conditions such as high protein diet, increased protein catabolism, GI hemorrhage,
dehydration, heart failure, etc. post-renal uremia is seen in malignancy, nephrolithiasis and prostatism.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/ 30114634

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on : 13-Aug-2025 / 10:55 AM
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 17:53 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CLINICAL CHEMISTRY I

Uric Acid, Serum
Investigation Observed Value Biological Reference Interval

Uric Acid. 5.0 3.4-7.0 mg/dL

Method:Uricase

Interpretation

It is the major product of purine catabolism. Hyperuricemia can result due to increased formation or decreased
excretion of uric acid which can be due to several causes like metabolic disorders, psoriasis, tissue hypoxia, pre-
eclampsia, alcohol, lead poisoning, acute or chronic kidney disease, etc. Hypouricemia may be seen in severe
hepato cellular disease and defective renal tubular reabsorption of uric acid.

* Sample processed at National Reference Laboratory,Tenet Diagnostics, Plot No.51, Kineta Towers, Journalist Colony,Road No.3, Banjarahills, Hyderabad

--- End Of Report ---

Dr Afreen Anwar
Consultant Biochemist

Page 1 of 1
Name : Mr . I VIKAS KAILAS TID : UMR3323769
Age/Gender : 22 Years/Male Registered On : 13-Aug-2025 10:50 AM
Ref By : Reported On : 13-Aug-2025 12:07 PM
[Link] : 25ASRP0001647 Reference : Granules Life Sciences
Private Limi

DEPARTMENT OF X­RAY
X­Ray Chest PA View

Lung fields appear normal.

Cardiac size is within normal limits.

Aorta and pulmonary vasculature is normal.

Bilateral domes of diaphragm and costophrenic angles are normal.

Visualised bones and soft tissues appear normal.

IMPRESSION:

* Normal study.

Suggested clinical correlation and follow up.

*** End Of Report ***

Dr Abhijith Kotte
MBBS, MD (MRCP)
Consultant Clinical Radiologist
Name : Mr . I VIKAS KAILAS TID : UMR3323769
Age/Gender : 22 Years/Male Registered On : 13-Aug-2025 10:50 AM
Ref By : Reported On : 13-Aug-2025 04:28 PM
[Link] : 25ASRP0001647 Reference : Granules Life Sciences
Private Limi

DEPARTMENT OF CARDIOLOGY
ECG(Electrocardiogram)
Sinus bradycardia
Rest within normal limits

­­­­­ Report Attached ­­­­­

*** End Of Report ***

Dr.O J UDAY KUMAR

Consultant Cardiologist
Name : Mr . I VIKAS KAILAS TID : UMR3323769
Age/Gender : 22 Years/Male Registered On : 13-Aug-2025 10:50 AM
Ref By : Reported On : 13-Aug-2025 01:47 PM
[Link] : 25ASRP0001647 Reference : Granules Life Sciences
Private Limi

DEPARTMENT OF CARDIOLOGY
Pulmonary Function Test (PFT)
Pre Test COPD Severity
Test within normal limits

­­­­ Report Attached ­­­­

*** End Of Report ***

Doctor
 PLEASE SCAN QR CODE
TO VERIFY THE REPORT ONLINE
25ASRP0001

Name : MR.I VIKAS KAILAS TID/SID : UMR3323769/

Age / Gender : 22 Years / Male Registered on : 13-Aug-2025 / 10:50 AM
[Link] : - Collected on :
[Link] : 25ASRP0001647 Reported on : 13-Aug-2025 / 13:47 PM
TEST REPORT Reference : Granules Life Sciences Pri

DEPARTMENT OF CARDIOLOGY
Physical Examination (BP, HT, WT, BMI)
Investigation Observed Value

BP 120/60
Weight 45.8 Kg
Height 173 cm
BMI 15.30
Pulse 70

Plot no: 101 Survey no : 459,460,461, Automic Energy

--- End Of Report ---

Doctor

Page 1 of 1
Name : Mr . I VIKAS KAILAS TID : UMR3323769
Age/Gender : 22 Years/Male Registered On : 13-Aug-2025 10:50 AM
Ref By : Reported On : 13-Aug-2025 01:13 PM
[Link] : 25ASRP0001647 Reference : Granules Life Sciences
Private Limi

AUDIOMETRY EXAMINATION
PTA TDT SIS SDT UCL Special Test
Right
Left
Diagnosis:

Right:

Left:

Recommendations:
*** End Of Report ***

Doctor
Name : Mr . I VIKAS KAILAS TID : UMR3323769
Age/Gender : 22 Years/Male Registered On : 13-Aug-2025 10:50 AM
Ref By : Reported On : 13-Aug-2025 01:12 PM
[Link] : 25ASRP0001647 Reference : Granules Life Sciences
Private Limi

EYE EXAMINATION

Chief Complaints:

Refraction Details

UVA SPHERE CYL AXIS ADD

CVA

Right

Left

Colour Blindness:

Note :­*Please note that the above details of power refraction is a part of the basic Eye
[Link] are requested to visit any of the speciality Eye hospitals for detailed and
final diagnosis.
*** End Of Report ***

Doctor